Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-23-037493
Filing Date
2023-10-17
Accepted
2023-10-17 16:15:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 133486
2 ex5-1.htm EX-5.1 25521
3 ex5-1_001.jpg GRAPHIC 12393
4 ex5-1_002.jpg GRAPHIC 13131
5 ex5-1_003.jpg GRAPHIC 6909
  Complete submission text file 0001493152-23-037493.txt   205061
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-268934 | Film No.: 231329783
SIC: 2834 Pharmaceutical Preparations